Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-κB activation

Cell Biochemistry and Function

Volumn 25, Issue 3, 2007, Pages 335-343

  Su, Hua Jiang ^a   Chun, Feng Liu ^a   Xiao, Li Zhang ^a   Xun, Hui Xu ^a   Jian, Zhou Zou ^a   Fang, Yi ^a   Ding, Xiao Qiang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Inflammation; Ischaemia reperfusion; Ischaemic preconditioning; Kidney; Nuclear factor B

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERSTITIAL NEPHRITIS; ISCHEMIC PRECONDITIONING; KIDNEY FUNCTION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

RATTUS;

EID: 34249674991     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1395     Document Type: Article

References (31)

1. Molls RR, Savransky V, Liu M, et al. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol 2006; 290: F1187-1193.
2. Sahna E, Parlakpinar H, Cihan OF, Turkoz Y, Acet A. Effects of aminoguanidine against renal ischaemia-reperfusion injury in rats. Cell Biochem Funct 2006; 24: 137-141.
3. Molitoris BA. Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 265-267.
4. Okubo S, Xi L, Bernardo NL, Yoshida K, Kukreja RC. Myocardial preconditioning: basic concepts and potential mechanisms. Mol Cell Biochem 1999; 196: 3-12.
5. Tomai F, Crea F, Chiariello L, Gioffrè PA. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation 1999; 100: 559-563.
6. Park KM, Byun JY, Kramers C, Kim JI, Huang PL, Bonventre JV. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-27266.
7. Muscari S, Bonafe' F, Gamberini C, Giordano E, Lenaz G, Caldarera CM. Ischemic preconditioning preserves proton leakage from mitochondrial membranes but not oxidative phosphorylation during heart reperfusion. Cell Biochem Funct (in press).
8. Baxter GF, Goma FM, Yellon DM. Characterization of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 1997; 92: 159-167.
9. Yamashita N, Hoshida S, Otsu K, Taniguchi N, Kuzuya T, Hori M. The involvement of cytokines in the second window of ischaemic preconditioning. Br J Pharmacol 2000; 131: 415-422.
10. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004; 66: 480-485.
11. Roelofs JJ, Rouschop KM, Leemans JC, et al. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol 2006; 17: 131-140.
12. Karin M, Delhase M, The I-κB kinase (IKK) and NF-κB: key elements of proinflammatory signalling. Semin Immunol 2000; 12: 85-98.
13. Cao CC, Ding XQ, Ou ZL, et al. In vivo transfection of NF-κB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 2004; 65: 834-845.
14. Thiemermann C, Patel NS, Kvale EO, et al. High density lipoprotein (HDL) reduces renal ischemia/reperfusion. J Am Soc Nephrol 2003; 14: 1833-1843.
15. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 1983; 35: 198-204.
16. Day YJ, Huang L, Ye H, Linden J, Okusa MD. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 2005; 288: F722-731.
17. Abraham E. NF-κB activation. Crit Care Med 2000; 28: N100-N104.
18. Yamamoto Y, Gaynor RB. IκB kinases: key regulators of the NF-κB pathway. Trends Biochem Sci 2004; 29: 72-79.
19. Torras J, Herrero-Fresneda I, Lloberas N, Riera M, Cruzado JM, Grinyó JM. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int 2002; 61: 2218-2227.
20. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001; 276: 11870-11876.
21. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15: 1562-1574.
22. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114: 5-14.
23. Haller H, Dragun D, Miethke A, et al. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 1996; 50: 473-480.
24. Kelly KJ, Williams WW, Jr, Colvin RB, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97: 1056-1063.
25. Donnahoo KK, Shames BD, Harken AH, Meldrum DR. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999; 162: 196-203.
26. Donnahoo KK, Meldrum DR, Shenkar R, Chung CS, Abraham E, Harken AH. Early renal ischemia, with or without reperfusion, activates NF kappaB and increases TNF-alpha bioactivity in the kidney. J Urol 2000; 163: 1328-1332.
27. Belosjorow S, Bolle I, Duschin A, Heusch G, Schulz R. TNF-α antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits. Am J Physiol Heart Circ Physiol 2003; 284: H927-H930.
28. Vos IH, Govers R, Grone HJ, et al. NF-kappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 2000; 14: 815-822.
29. Guijarro C, Egido J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 2001; 59: 415-424.
30. Sung FL, Zhu TY, Au-Yeung KK, Siow YLOK. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 2002; 62: 1160-1170.
31. Chatterjee PK, Di Villa BRD, Sivarajah A, McDonald MC, Cuzzocrea S, Thiemermann C. Pyrrolidine dithiocarbamate reduces renal dysfunction and injury caused by ischemia/reperfusion of the rat kidney. Eur J Pharmacol 2003; 482: 271-280.